AMRX
USDAmneal Pharmaceuticals Inc. Class A Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$11.010
High
$11.400
Low
$10.940
Volume
3.47M
Company Fundamentals
Market Cap
3.6B
Industry
Drug Manufacturers - Specialty & Generic
Country
United States
Trading Stats
Avg Volume
1.66M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Piper Sandler Reiterates Overweight on Amneal Pharmaceuticals, Raises Price Target to $13
Piper Sandler analyst David Amsellem reiterates Amneal Pharmaceuticals with a Overweight and raises the price target from $11 to $13.
Amneal Reports Third Quarter 2025 Financial Results
‒ Q3 2025 Net Revenue of $785 million; GAAP Net Income of $2 million; Diluted Income per Share of $0.01 ‒‒ Adjusted EBITDA of $160 million; Adjusted Diluted EPS of $0.17 ‒‒ Updated 2025 Full Year Guidance ‒ BRIDGEWATER,
Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol
BRIDGEWATER, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has tentatively approved the Company's
Related Stocks
RDI
Reading International Inc
LAB
Standard BioTools Inc.
NSA
National Storage Affiliates Trust Common Shares of Beneficial Interest
PWSC
PowerSchool Holdings Inc.
ADAG
Adagene Inc. American Depositary Shares
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.